Binhui Biopharmaceutical Co., Ltd.

Quick facts

Phase 3 pipeline

• OH2 injection · Oncology
  OH2 injection is a monoclonal antibody that targets the PD-1 receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Binhui Biopharmaceutical Co., Ltd. portfolio CI brief
• Binhui Biopharmaceutical Co., Ltd. pipeline updates RSS